1,582
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Percutaneous thermal ablation of hepatocellular carcinomas located in the hepatic dome using artificial carbon dioxide pneumothorax: retrospective evaluation of safety and efficacy

, , , , , , , , & show all
Pages 90-96 | Received 18 Mar 2018, Accepted 13 May 2018, Published online: 20 Jun 2018

References

  • European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943.
  • Kim J-E, Kim Y-S, Rhim H, et al. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol. 2011;79:e80–e84.
  • de Baère T, Dromain C, Lapeyre M, et al. Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience. Radiology. 2005;236:666–670.
  • Kambadakone A, Baliyan V, Kordbacheh H, et al. Imaging guided percutaneous interventions in hepatic dome lesions: tips and tricks. World J Hepatol. 2017;9:840–889.
  • Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004;239:450–458.
  • Zheng X-H, Guan Y-S, Zhou X-P, et al. Detection of hypervascular hepatocellular carcinoma: comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT. World J Gastroenterol. 2005;11:200–203.
  • Maher MM, Gervais DA, Kalra MK, et al. The inaccessible or undrainable abscess: how to drain it. Radiographics. 2004;24:717–735.
  • Kang TW, Rhim H, Lee MW, et al. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy. Am J Roentgenol. 2011; 196:907–913.
  • Lee EJ, Rhim H, Lim HK, et al. Effect of artificial ascites on thermal injury to the diaphragm and stomach in radiofrequency ablation of the liver: experimental study with a porcine model. Am J Roentgenol. 2008;190:1659–1664.
  • Song I, Rhim H, Lim HK, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol. 2009;19:2630–2640.
  • Brennan DD, Ganguli S, Brecher CW, et al. Thinking outside the abdominal box: safe use of the epipericardial fat pad window for percutaneous radiofrequency ablation of hepatic dome tumors. J Vasc Interv Radiol. 2008;19:133–136.
  • Kondo Y, Yoshida H, Tateishi R, et al. Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique. Br J Surg. 2008;95:996–1004.
  • Choi TW, Lee JM, Lee DH, et al. Percutaneous dual-switching monopolar radiofrequency ablation using a separable clustered electrode: a preliminary study. Korean J Radiol. 2017;18:799–808.
  • Cardella JF, Kundu S, Miller DL, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2009;20:S189–S91.
  • Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009;20(7 Suppl):S377–S390.
  • Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17:684–692.
  • Lee DH, Lee JM, Lee JY, et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology. 2014;270:900–909.
  • Kim Y, Rhim H, Cho OK, et al. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol. 2006;59:432–441.
  • Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107:569–577.
  • Kim Y, Lim HK, Rhim H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol. 2013;58:89–97.
  • Veress J. Neues instument zur ausführung von brust-oder bauch-punktionen und pneumothoraxbehandlung. Dtsch Med Wochenschr. 1938;64:1480–1481.
  • Akahane M, Koga H, Kato N, et al. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiogr Rev Publ Radiol Soc N Am Inc. 2005;25:S57–S68.
  • Fujiwara H, Arai Y, Ishii H, et al. Computed tomography-guided radiofrequency ablation for sub-diaphragm hepatocellular carcinoma: safety and efficacy of inducing an artificial pneumothorax. Acta Med Okayama. 2016;70:189–195.
  • Okuma T, Matsuoka T, Tutumi S, et al. Air embolism during needle placement for CT-guided radiofrequency ablation of an unresectable metastatic lung lesion. J Vasc Interv Radiol. 2007;18:1592–1594.
  • Favelier S, Guiu S, Cherblanc V, et al. Transthoracic adrenal biopsy procedure using artificial carbon dioxide pneumothorax as outpatient procedure. Cardiovasc Intervent Radiol. 2013;36:1184–1187.
  • Buy X, Tok C-H, Szwarc D, et al. Thermal protection during percutaneous thermal ablation procedures: interest of carbon dioxide dissection and temperature monitoring. Cardiovasc Intervent Radiol. 2009;32:529–534.
  • Kariya S, Tanigawa N, Kojima H, et al. Radiofrequency ablation combined with CO2 injection for treatment of retroperitoneal tumor: protecting surrounding organs against thermal injury. Am J Roentgenol. 2005;185:890–893.
  • Hiraki T, Gobara H, Shibamoto K, et al. Technique for creation of artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors: report of seven cases. J Vasc Interv Radiol. 2011;22:503–506.